Clinical trial NCT03211559: Clinical Pilates and Aerobic Exercise in Patients With Ankylosing Spondylitis
Official title: Investigating the Effectiveness of Clinical Pilates Exercise When Applied Together With Aerobic Exercise in Patients With Ankylosing Spondylitis
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Exercise
Ankylosing Spondylitis
Keywords: ankylosing spondylitis
clinical pilates exercise
aerobic exercise
functional exercise capacity
pulmonary function
Lead sponsor: Eastern Mediterranean University
Sponsor class: OTHER
First posted: 2017-07-07
Enrollment: 36
Sex: ALL
Minimum age (years): 20
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The aim of our study is to investigate the effect of Clinical Pilates Exercises on functional status and quality of life when applied together with aerobic exercise in patients with ankylosing spondylitis (AS).

Detailed description: According to the power analyzes 32 patients, who were diagnosed as Ankylosing spondylitis, will be taken to the study. In the first session their spinal mobility, flexibility, dynamic and static balance, back and lower limb muscle strength, pulmonary functions and pulmonary muscle strength, disease activity level, fatigue level, functional exercise capacity will be assessed to determine functional status by a physiotherapist. Also their quality of life and factors affecting the quality will be assessed. Then the patients will be divided into two exercise groups randomly. Patients in the first group will only do aerobic exercise, patients in the second group will do clinical pilates additional to the aerobic exercise which has the same protocol with the first group. Patients will do the exercise for 8 weeks, 3 times a day individually with a physiotherapist . At the end of the 8 weeks they will be assessed with the same tests again.

Eligibility criteria: Inclusion Criteria:

- Man and woman diagnosed with ankylosing spondylitis .

Exclusion Criteria:

* Any neurological or muscle diseases
* Inability to continuously attend the exercise program
* Visual, hearing or mental problems that could prevent communication
* Using mobility aids
* Pregnancy
* Malignity
* Having a surgery recently
* Doing exercise regularly in last 3 months.
* Having a cardiopulmonary problem which is not under control.

Primary outcomes:
measure: Aerobic capacity will be detected with submaximal exercise testing (modified Bruce protocol).
timeFrame: Change from Baseline and at the end of 8 weeks
Secondary outcomes:
measure: Lateral spinal flexion distance was measured
timeFrame: At the begining and at the end of 8 weeks.
measure: Lumbal flexion distance was measured
timeFrame: At the begining and at the end of 8 weeks.
measure: Tragus to wall distance was measured
timeFrame: At the begining and at the end of 8 weeks.
measure: Intermalleoler distance was measured
timeFrame: At the begining and at the end of 8 weeks.
measure: servical rotation was measured
timeFrame: At the begining and at the end of 8 weeks.
measure: Spinal mobility of the chest will be measured with chest circumference test.
timeFrame: At the begining and at the end of 8 weeks.
measure: Flexibility of the upper extremity will be measured with back scratch test.
timeFrame: At the begining and at the end of 8 weeks.
measure: Static balance of the patients will be tested with single leg stance test.
timeFrame: At the beginning and at the end of 6 weeks
measure: Dynamic balance of the patients will be tested with functional reach test.
timeFrame: At the beginning and at the end of 6 weeks
measure: Strength and endurance of the lower extremities will be tested with Chair Sit and Stand Test
timeFrame: At the beginning and at the end of 6 weeks
measure: The isometric strength of the back and lower extremity muscles will be measured with a dynamometer.
timeFrame: At the beginning and at the end of 6 weeks
measure: Functionality of the patients will be measured with Vath Ankylosing Spondylitis Functionality Index.
timeFrame: At the beginning and at the end of 6 weeks
measure: Disease activity level be measured with Bath Ankylosing Spondylitis Disease Activity Index.
timeFrame: At the beginning and at the end of 6 weeks
measure: Lung volumes and pulmonary functions will be tested with spirometric function tests.
timeFrame: At the beginning and at the end of 6 weeks
measure: the strength of pulmonar muscles will be measured with Maximal Inspiratory Presssure and Maximal Expiratory Pressure inside the mouth.
timeFrame: At the beginning and at the end of 6 weeks
measure: Fatigue will be evaluated by the Multidimensional Fatigue Inventory (MFI)
timeFrame: At the beginning and at the end of 6 weeks
measure: Fatigue severity level of the patient will be evaluated by the Fatigue Severity Scale.
timeFrame: At the beginning and at the end of 6 weeks
measure: Sleep quality level of the patient will be evaluated by the Pitsburg Sleep Quality Index .
timeFrame: At the beginning and at the end of 6 weeks.
measure: Exercise capacity will be tested by the 6 minute walk test.
timeFrame: At the beginning and at the end of 6 weeks.
measure: Quality of life of the patients will be determined with Ankylosing Spondylitis Quality of Life Scale.
timeFrame: At the beginning and at the end of 6 weeks.
measure: Change in the level of anxiety and depression assessed using Hospital Anxiety and Depression Scale at 6 weeks.
timeFrame: At the beginning and at the end of 6 weeks.
measure: Change in the level of fear and avoidance associated with movement assessed using the Tampa Kinesiophobia Scale at 6 weeks.
timeFrame: At the beginning and at the end of 6 weeks.
Other outcomes:
Locations:
city: Famagusta
country: Cyprus
facility: Eastern Mediterranen University
Study officials:
affiliation: Eastern Mediterranean University
name: Oksuz
role: PRINCIPAL_INVESTIGATOR
References: